denosumab solution for inection 120 mg/1.7 ml
Denosumab is a RANK ligand (RANKL) inhibitor. It works by binding to RANKL, a protein essential for the formation and activity of osteoclasts (cells that break down bone). By inhibiting bone resorption, it helps strengthen bones and reduces the risk of fractures caused by cancer.
Click to expand
Anti Cancer Injection
denosumab solution for inection 120 mg/1.7 ml
By Intas Pharmaceuticals
₹9,800
WHO-GMP
ISO Certified
Trusted Exporter
Secure Supply
Strength
120 mg / 1.7 mL
Packaging
Available as a single-dose vial containing 1.7 ml of solution.
Type
Usually supplied in a Glass Vial packed within a cardboard Box.
Shelf Life
36 months (3 years)
Denosumab is a RANK ligand (RANKL) inhibitor. It works by binding to RANKL, a protein essential for the formation and activity of osteoclasts (cells that break down bone). By inhibiting bone resorption, it helps strengthen bones and reduces the risk of fractures caused by cancer.
Manufacturer Info
NameIntas Pharmaceuticals
PrescriptionPrescription-only (Rx).
Global Compliance
Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.